Featured Research

from universities, journals, and other organizations

Call to tighten up value for money appraisals of new drugs in England

Date:
December 14, 2013
Source:
BMJ-British Medical Journal
Summary:
The body that appraises the clinical and cost effectiveness of new drugs in England would do well to take a leaf out of its sister organizations' books in Wales and Scotland, says an editorial in the Drug and Therapeutics Bulletin.

The body that appraises the clinical and cost effectiveness of new drugs in England would do well to take a leaf out of its sister organizations' books in Wales and Scotland, says an editorial in the Drug and Therapeutics Bulletin (DTB).

Between 30% and 40% of all new drug appraisals in the three countries have to be jettisoned, because the manufacturer in question has failed to supply the evidence needed to make the case for the drug, says DTB.

But unlike Scotland and Wales, where this situation usually prompts a recommendation for the drug to be rejected for use in the NHS, this is not the case in England, where such decisions are usually left up to the discretion of the local decision-making bodies.

This leads to "the inevitable duplication of effort and the potential for postcode availability," it says.

"We believe that England should follow the example of Scotland and Wales and not support use of a medicine when the company does not comply with the submission process," it contends.

While the appraisal processes in Scotland and Wales cover most new drugs and licensed indications for treatment, this responsibility largely falls to local commissioning groups in England.

DTB therefore also suggests that it might be more efficient and economical if just one UK body was responsible for evaluating the clinical and cost effectiveness of new drugs, given that all three bodies will be reviewing the same data.

"It could be argued that in a time of financial austerity, it might be more economical to run a single UK appraisal service to supply the same information to each appraisal committee (national or local)," it says.

Twenty years ago the NHS general practice drug bill came to 2.6 billion a year. Now those same costs have quadrupled to more than 10 billion a year.

During this time, the systems for evaluating the financial and clinical benefits of drugs has vastly improved across the UK, with the creation of three authoritative bodies in England, Wales, and Scotland, says DTB.

But these organizations shouldn't be resting on their laurels, just yet, it says.


Story Source:

The above story is based on materials provided by BMJ-British Medical Journal. Note: Materials may be edited for content and length.


Cite This Page:

BMJ-British Medical Journal. "Call to tighten up value for money appraisals of new drugs in England." ScienceDaily. ScienceDaily, 14 December 2013. <www.sciencedaily.com/releases/2013/12/131214144852.htm>.
BMJ-British Medical Journal. (2013, December 14). Call to tighten up value for money appraisals of new drugs in England. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2013/12/131214144852.htm
BMJ-British Medical Journal. "Call to tighten up value for money appraisals of new drugs in England." ScienceDaily. www.sciencedaily.com/releases/2013/12/131214144852.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Working Mother (Oct. 22, 2014) Is your child ready? Video provided by Working Mother
Powered by NewsLook.com
U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

Newsy (Oct. 22, 2014) Now that the U.S. is restricting travel from West Africa, some are dropping questions about a travel ban and instead asking about visa bans. Video provided by Newsy
Powered by NewsLook.com
US to Track Everyone Coming from Ebola Nations

US to Track Everyone Coming from Ebola Nations

AP (Oct. 22, 2014) Stepping up their vigilance against Ebola, federal authorities said Wednesday that everyone traveling into the US from Ebola-stricken nations will be monitored for symptoms for 21 days. (Oct. 22) Video provided by AP
Powered by NewsLook.com
Doctors Help Paralysed Man Walk Again, Patient in Disbelief

Doctors Help Paralysed Man Walk Again, Patient in Disbelief

AFP (Oct. 22, 2014) Polish doctors describe how they helped a paralysed man walk again, with the patient in disbelief at the return of sensation to his legs. Duration: 1:04 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins